These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36287606)

  • 1. Validation of an Electronic Visual Analog Scale App for Pain Evaluation in Children and Adolescents With Symptomatic Hypermobility: Cross-sectional Study.
    Maarj M; Pacey V; Tofts L; Clapham M; Gironès Garcia X; Coda A
    JMIR Pediatr Parent; 2022 Oct; 5(4):e41930. PubMed ID: 36287606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a Mobile Health Electronic Visual Analog Scale App With a Traditional Paper Visual Analog Scale for Pain Evaluation: Cross-Sectional Observational Study.
    Turnbull A; Sculley D; Escalona-Marfil C; Riu-Gispert L; Ruiz-Moreno J; Gironès X; Coda A
    J Med Internet Res; 2020 Sep; 22(9):e18284. PubMed ID: 32940621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of pain with gait spatiotemporal parameters in children with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder.
    Jeong HJ; Engel JM; Muriello M; Basel D; Slavens BA
    Gait Posture; 2024 Mar; 109():271-276. PubMed ID: 38368648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of an Electronic Visual Analog Scale mHealth Tool for Acute Pain Assessment: Prospective Cross-Sectional Study.
    Escalona-Marfil C; Coda A; Ruiz-Moreno J; Riu-Gispert LM; Gironès X
    J Med Internet Res; 2020 Feb; 22(2):e13468. PubMed ID: 32049063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fear avoidance, fear of falling, and pain disability in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Chuchin JD; Ornstein TJ
    Disabil Rehabil; 2023 Oct; ():1-12. PubMed ID: 37843031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of ADHD and Autism Spectrum Disorder in Children with Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome: A Retrospective Study.
    Kindgren E; Quiñones Perez A; Knez R
    Neuropsychiatr Dis Treat; 2021; 17():379-388. PubMed ID: 33603376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An online pain management program for people with hypermobile Ehlers-Danlos Syndrome or hypermobility spectrum disorder: a three-staged development process.
    Chew MT; Ilhan E; Nicholson LL; Kobayashi S; Chan C
    Disabil Rehabil; 2024 May; ():1-11. PubMed ID: 38738812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and Management of Dyspnea in Hypermobile Ehlers-Danlos Syndrome and Generalized Hypermobility Spectrum Disorder: Protocol for a Pilot and Feasibility Randomized Controlled Trial.
    Rozenberg D; Al Kaabi N; Camacho Perez E; Nourouzpour S; Lopez-Hernandez L; McGillis L; Goligher E; Reid WD; Chow CW; Ryan CM; Kumbhare D; Huszti E; Champagne K; Raj S; Mak S; Santa Mina D; Clarke H; Mittal N
    JMIR Res Protoc; 2023 Mar; 12():e44832. PubMed ID: 36939815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of gastrointestinal function and its' effect on bone mineral density and body composition in hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome.
    DiFrancisco-Donoghue J; Southard V; Margulies M; Jung MK; Allera A; Riley B
    J Clin Densitom; 2022; 25(4):536-543. PubMed ID: 35945116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An exploratory study of clinical characteristics and gait features of adolescents with hypermobility disorders.
    de Koning LE; Scheper MC; Ploeger HE; Warnink-Kavelaars J; Oosterlaan J; Bus SA; Engelbert RHH
    Gait Posture; 2023 Feb; 100():222-229. PubMed ID: 36638668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobile spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities.
    Fairweather D; Bruno KA; Darakjian AA; Bruce BK; Gehin JM; Kotha A; Jain A; Peng Z; Hodge DO; Rozen TD; Munipalli B; Rivera FA; Malavet PA; Knight DRT
    Front Med (Lausanne); 2023; 10():1096180. PubMed ID: 37181352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory.
    Bennett SE; Walsh N; Moss T; Palmer S
    Disabil Rehabil; 2022 Sep; 44(18):5231-5240. PubMed ID: 34101520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermobility spectrum disorders and active migraine in Israeli adolescents: A nationwide study.
    Zloof Y; Simchoni M; Derazne E; Tsur AM; Tzur D; Braun M; Amarilyo G; Shlaifer A; Honig A; Braun-Moscovici Y
    Headache; 2023; 63(7):934-941. PubMed ID: 37313588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered Multisegment Ankle and Foot Kinematics During Gait in Patients With Hypermobile Ehlers-Danlos Syndrome/Hypermobility Spectrum Disorder: A Case-Control Study.
    Vermeulen S; De Mits S; De Ridder R; Calders P; De Schepper J; Malfait F; Rombaut L
    Arthritis Care Res (Hoboken); 2022 May; 74(5):841-848. PubMed ID: 33275840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are patients with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder so different?
    Aubry-Rozier B; Schwitzguebel A; Valerio F; Tanniger J; Paquier C; Berna C; Hügle T; Benaim C
    Rheumatol Int; 2021 Oct; 41(10):1785-1794. PubMed ID: 34398260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central sensitization in adolescents with hypermobility spectrum disorder or hypermobile Ehlers-Danlos syndrome-a feasibility study.
    Schubert-Hjalmarsson E; Fasth A; Ickmans K; Mårdbrink EL; Söderpalm AC; Lundberg M
    Pilot Feasibility Stud; 2023 Jun; 9(1):97. PubMed ID: 37316864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone parameters in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder: A comparative cross-sectional study.
    Coussens M; Banica T; Lapauw B; De Wandele I; Rombaut L; Malfait F; Calders P
    Bone; 2023 Jan; 166():116583. PubMed ID: 36243401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting quality of life in children and adolescents with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders.
    Mu W; Muriello M; Clemens JL; Wang Y; Smith CH; Tran PT; Rowe PC; Francomano CA; Kline AD; Bodurtha J
    Am J Med Genet A; 2019 Apr; 179(4):561-569. PubMed ID: 30703284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Hypermobile "Ehlers-Danlos Syndrome" and Hypermobile Spectrum Disorder on Interpersonal Interactions and Relationships.
    De Baets S; De Temmerman M; Calders P; Malfait F; Van Hove G; Vanderstraeten G; De Wandele I; Van de Velde D
    Front Rehabil Sci; 2022; 3():832806. PubMed ID: 36188999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermobility spectrum disorders and irritable bowel syndrome: A nationwide study of 1.6 million adolescents.
    Zloof Y; Peretz L; Braun M; Simchoni M; Tsur AM; Tzur D; Derazne E; Ben-Tov A; Pinhas-Hamiel O; Amarilyo G; Daher S; Shlaifer A; Braun-Moscovici Y
    J Gastroenterol Hepatol; 2023 Dec; 38(12):2076-2082. PubMed ID: 37658800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.